Warning letter
Guilin Pharmaceutical Corporation, Limited: warning letter of Jun 23, 2006
FDA warning letter UCM075956 · Center for Veterinary Medicine
Key facts
| Reference number | UCM075956 |
|---|---|
| Company | Guilin Pharmaceutical Corporation, Limited |
| Subject | Current Good Manufacturing Practices/Active Pharmaceuticals Ingredient/Adulterated |
| Issue date | Jun 23, 2006 |
| Posted date | Jun 23, 2006 |
| Issuing office | Center for Veterinary Medicine |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Guilin |
| Inspection start date | Mar 13, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: